Hyperhomocysteinemia can be ameliorated by dimethylsulfoniopropionate in place of folic acid in mice

Journal of Nutritional Science and Vitaminology

Volumn 52, Issue 1, 2006, Pages 61-65

  Nakajima, Kenji ^a  

^a KOSHIEN UNIVERSITY   (Japan)

Author keywords

Dimethylsulfoniopropionate; Folic acid; Glycine betaine; Hyperhomocysteinemia; Mice

Indexed keywords

BETAINE; DIMETHYLSULFONIOPROPIONATE; FOLIC ACID; HOMOCYSTEINE; PROPIONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; DRUG INHIBITION; DRUG MECHANISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERHOMOCYSTEINEMIA; MOUSE; NONHUMAN;

ANIMALS; BETAINE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FOLIC ACID; HOMOCYSTEINE; HYPERHOMOCYSTEINEMIA; INJECTIONS, INTRAPERITONEAL; KINETICS; MALE; MICE; MICE, INBRED ICR; SULFONIUM COMPOUNDS;

ANIMALIA;

EID: 33645774142     PISSN: 03014800     EISSN: 18817742     Source Type: Journal    
DOI: 10.3177/jnsv.52.61     Document Type: Article

References (35)

1. Johan B, Ubbink Dsc. 1995. Homocysteine, an atherogenic and a thrombogenic factor? Nutr Rev 53: 323-325.
2. Welch GN, Loscalzo J. 1998. Homocysteine and atherothrombosis. N Eng Med 9: 1042-1050.
3. McCully KS. 1969. Vascular pathology of homocystenemia: implications for the pathogenesis if artherosclerosis. Am J Pathol 56: 111-128.
4. Selhub J, Dangelo A. 1998. Relationship between homocysteine and thrombotic disease. Am J Med Sci 316: 129-141.
5. Jacobsen DW. 1998. Homocysteine and vitamins in cardiovascular disease. Clin Chem 44: 1833-1843.
6. Friedman JA, Dwyer JT. 1995. Hyperhomocystenemia as a risk factor for cardiovascular disease in patients undergoing hemodialysis. Nutr Rev 53: 197-201.
7. Selhub J, Jacques PF, Bostom AG, D'Agostino RB, Wilson PW, Belanger AJ, O'Leary DH, Wolf PA, Schaefer EJ, Rosenberg IH. 1995. Association between plasma homocysteine contents and extracranial carotid-artery stenosis. New Engl J Med 332: 289-291.
8. Den Heijen M, Blom HJ, Gerits WBJ, Rosendaal FR, Haak HL, Wijerman PW, Bos GMJ. 1995. Is hyperhomocystenemia a risk factor for recurrent venous thrombosis? Lancet 345: 882-885.
9. Yoo JH, Chung CS, Kang SS. 1998. Relation of plasma homocysteine to cerebral infarction and cerebral atherosclerosis. Stroke 29: 2478-2483.
10. 12 and neuropsychiatric disorders. Nutr Rev 54: 382-390.
11. 12 serum total homocysteine levels in confirmed Alzheimer disease. Arch Neurol 55: 1449-1455.
12. Chauveau P, Chadefaux B, Aupett J, Hannedouche T, Kamoun P, Jungas P. 1993. Hyperhomocystenemia, a risk factor for atherosclerosis chronic uremic patients. Kidney Int 43:872-77.
13. Hulberg B, Anderson A, Sterner G. 1995. Plasma homocysteine and traditional cardiovascular disease risk factors in end-stage renal disease patient on dialysis: a case-control study. Atherosclerosis 114: 93-103.
14. Eskes TKAB. 1998. Open or closed? A world of difference: A history of homocysteine research. Nutr Rev 66: 236-244.
15. Nelen WLDM, Blom HJ, Thomas CMG, Steegers EAP, Boers GHJ, Eskes TKA. 1998. Tetrahydrofolate reductase polymorphism affects the change in homocysteine and folate concentrations resulting from low dose folic acid supplementation in women with unexpected recurrent miscarriages. J Nutr 128: 1336-1341.
16. Stehouwer CDA, Gall MA, Hougaard D, Parving HH. 1999. Plasma homocysteine concentration predicts mortality in non-insulin-dependent diabetic patients with and without albuminurea. Kidney Int 55: 308-314.
17. Smulders YM, Rakic M, Slaats EM, Treskes M, Subrands EJG, Odekeren DAM, Stehouwer CDA, Silberbush J. 1999. Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopasy, albuminuria, and cardiovascular disease. Diabetes Care 22: 125-132.
18. Maw GA. 1956. Thetin-homocysteine transmethylase. A preliminary manometric study of the enzyme from rat liver. Biochemistry 63: 116-124.
19. Maw GA. 1959. Thetin-homocysteine transmethylase. The distribution of the enzyme, studied with the aid of trimethylsulphonium chloride as substrate. Biochemistry 73: 602-608.
20. Nakajima K. 1993. Dimethylthetin- and betaine-homocysteine methyltransferase activities from livers of fish and mammals. Bull Jap Soc Sci Fish 59: 1389-1393.
21. Nakajima K. 1996. Effects of DMSP and related compounds on behavior, growth and stress resistance of fish, amphibians and crustaceans. In: Biological and Environmental Chemistry of DMSP and Related Sulfonium Compounds (Kiene RP. Visscher PT, Keller MD. Kirst GO, eds), p 165-176. Plenum Press, New York and London.
22. Public Health Service, National Institute of Health. 1985. Guide for the Care and Use of Laboratory Animals. NIH Publication No. 86-23, Revised.
23. Nakajima K. 2003. Effect of the diets containing the green alga, Monostroma nitidum, on the senile phenomena of the senescence accelerated mouse. ITE Lett 3: 367-370.
24. Iida H. 1988. Studies on the accumulation of dimethyl-β-propiothetin and the formation of dimethyl sulfide in aquatic organisms. Bull Tokai Teg Fish Res Lab 124: 35-111 (in Japanese).
25. Lynn B, Jesse FG. 1999. Folate metabolism and requirements. Recent advances in nutritional science. J Nutr 129: 779-782.
26. O'keefe C, Bailey LB, Thomas EA, Holfer SA, Davis BA, Cerda JJ, Gregory JF. 1995. Controlled dietary folate affects folate status in nonpregnant women. J Nutr 125: 2717-2725.
27. Food and Nutrition Board, Institute of Medicine, National Academy of Science, Subcommittee on Folate, Other B Vitamins, and Choline. 1998. Dietary Reference Intakes: Thiamine. Roboflavin, Niacin, Vitamin B-6, Folate, Vitamin B-12, Panthothenic Acid, Biotin and Choline (pre-publication). National Academy Press, Washington DC.
28. Nakajima K. 2003. Direct effect of high concentrations of dimethyl-sulfoniopropionate, vitamin E and ferulic acid on the senility of adult Senescence Accelerated Mouse (SAM-P/8). ITE Lett 4: 357-361.
29. Nakajima K. 2004. Direct effects of high concentrations of dimethylsulfoniopropionate, vitamin U and ferulic acid on the senility of aged senescence accelerated mouse (SAMP8). J Nutr Sci Vitaminol 50: 231-237.
30. Nakajima K. 2002. The long term effect of dimethylsulfoniopropionate on the senility of senescence accelerated mouse-R/1 and-P/8. ITE Lett 3. 616-622.
31. Nakajima K. 2005. Remarkable effects of dimethylsulfoniopropionate on the loss of learning and memory of senescence accelerated mounse (SAMP1). ITE Lett 6: 68-72.
32. Nakajima K. 1991. Dimethyl-β-propiothetin, a new potent resistive-agent against stress-induced gastric ulcers in rats. J Nutr Sci Vitaminol 37: 229-238.
33. Nakajima K. 2004. Ameliorating effects of dimethylsulfoniopropionate on the ulcers in senescence accelerated mouse (SAMP1). Bull Koshien Univ 32A: 1-6.
34. Nakajima K. 2004. Effect of a sulfur-containing compound, dimethyl-sulfoniopropionate, on acute alloxan-diabetic rats. ITE Lett 5: 394-398.
35. Nakajima K, Minematsu M. 2002. Suppressive effects of dimethylsulfoniopropionate on 3′-methyl-4-dimethylaminoazobenzene-induced liver cancers in rats. ITE Lett 3: 371-374.